✦ LIBER ✦

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients

✍ Scribed by K. M. L. Crommentuyn; B. S. Kappelhoff; J. W. Mulder; A. T. A. Mairuhu; E. C. M. Van Gorp; P. L. Meenhorst; A. D. R. Huitema; J. H. Beijnen

Book ID: 108641405
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 265 KB
Volume: 60
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2005.02455.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetics of indinavir

Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patients

✍ Bregt S. Kappelhoff; Alwin D. R. Huitema; Sanjay U. C. Sankatsing; Pieter L. Mee 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Lopinavir/ritonavir resistance in patien

Lopinavir/ritonavir resistance in patients infected with HIV-1: two divergent resistance pathways?

✍ Karen Champenois; Agathe Baras; Philippe Choisy; Faiza Ajana; Hughes Melliez; La 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 1 views

## Abstract The HIV‐1 protease L76V mutation has been described recently as conferring high‐level resistance to lopinavir/ritonavir (LPV/r). The aim was to identify the factors and particularly protease mutations associated with the presence of L76V in treatment‐experienced patients infected with H

Population pharmacokinetics of atazanavi

Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescents

✍ Frantz Foissac; Stéphane Blanche; Catherine Dollfus; Déborah Hirt; Ghislaine Fir 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB

Population pharmacokinetics of lopinavir

Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children

✍ Doaa Elsherbiny; Yuan Ren; Helen McIlleron; Gary Maartens; Ulrika S. H. Simonsso 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 224 KB

Lopinavir–Ritonavir Dramatically Affects

Lopinavir–Ritonavir Dramatically Affects the Pharmacokinetics of Irinotecan in HIV Patients With Kaposi’s Sarcoma

✍ Corona, G; Vaccher, E; Sandron, S; Sartor, I; Tirelli, U; Innocenti, F; Toffoli, 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Absence of circadian variation in the ph

Absence of circadian variation in the pharmacokinetics of lopinavir/ritonavir given as a once daily dosing regimen in HIV-1-infected patients

✍ R. P. G. Van Heeswijk; M. Bourbeau; I. Seguin; P. Giguere; G. E. Garber; D. W. C 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB